Call Us
888.433.2300
Dexamethasone Sodium Phosphate 10 mg / mL Injection 10 mL, 10/Box
$77.95
- Medex SKU:
- MYL-67457042010
- Packing Info:
- 10/Box
- Usually Ships:
- 3 - 5 Business Days
- Notice:
- Due to regulatory requirements, this item can only be shipped to customers who have a valid Medical license on file. To add your license information, please click here
Description
Key Features:
Active Ingredient: Dexamethasone Sodium Phosphate (equivalent to Dexamethasone Phosphate).
Strength: 10 mg/mL (100 mg/10 mL per vial).
Dosage Form: Injection, a sterile, clear, colorless solution.
Container Type: Typically supplied in a 10 mL multiple-dose vial.
Manufacturer: Mylan Pharmaceuticals.
Route of Administration: Primarily for intravenous (IV) or intramuscular (IM) use. The 4 mg/mL strength may also be used for intra-articular, intralesional, and soft tissue administration.
Classification: Adrenal Glucocorticoid, Corticosteroid.
Uses:
Dexamethasone Sodium Phosphate is a corticosteroid used for its potent anti-inflammatory and immunosuppressive effects. It treats a wide range of conditions, particularly when oral therapy isn't feasible. Its uses include:
Endocrine Disorders: Primary or secondary adrenocortical insufficiency (often as an adjunct to other therapies), acute adrenocortical insufficiency, preoperative and in cases of trauma or illness for patients with known or suspected adrenal insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, and hypercalcemia associated with cancer.
Rheumatic Disorders (as adjunctive therapy for acute episodes or exacerbations): Rheumatoid arthritis (including juvenile rheumatoid arthritis), osteoarthritis (post-traumatic, synovitis), acute and subacute bursitis, epicondylitis, acute nonspecific tenosynovitis, acute gouty arthritis, psoriatic arthritis, and ankylosing spondylitis.
Collagen Diseases: Systemic lupus erythematosus, acute rheumatic carditis.
Dermatologic Diseases: Pemphigus, severe erythema multiforme (Stevens-Johnson Syndrome), exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe psoriasis, and mycosis fungoides.
Allergic States (for severe or incapacitating conditions intractable to conventional treatment): Bronchial asthma, contact dermatitis, atopic dermatitis, serum sickness, seasonal or perennial allergic rhinitis, drug hypersensitivity reactions, urticarial transfusion reactions, and acute noninfectious laryngeal edema.
Ophthalmic Diseases (severe acute and chronic allergic and inflammatory processes involving the eye): Herpes zoster ophthalmicus, iritis, iridocyclitis, chorioretinitis, diffuse posterior uveitis and choroiditis, optic neuritis, sympathetic ophthalmia, anterior segment inflammation, allergic conjunctivitis, allergic corneal marginal ul
cers, and keratitis. Gastrointestinal Diseases (to tide the patient over a critical period): Ulcerative colitis (systemic therapy), regional enteritis (systemic therapy).
Respiratory Diseases: Symptomatic sarcoidosis, berylliosis, fulminating or disseminated pulmonary tuberculosis (with anti-tuberculosis chemotherapy), Loeffler's syndrome, and aspiration pneumonitis.
Hematologic Disorders: Acquired (autoimmune) hemolytic anemia, idiopathic thrombocytopenic purpura in adults (IV only), secondary thrombocytopenia in adults, erythroblastopenia, and congenital (erythroid) hypoplastic anemia.
Neoplastic Diseases (for palliative management): Leukemias and lymphomas in adults, acute leukemia of childhood.
Edematous States: To induce diuresis or remission of proteinuria in nephrotic syndrome.
Nervous System: Acute exacerbations of multiple sclerosis, cerebral edema of diverse etiologies.
Diagnostic Use: Diagnostic testing of adrenocortical hyperfunction.